8-K
 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) March 22, 2004

WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORPORATION

(Exact Name of Registrant as Specified in its Charter)
         
Delaware   1-13782   25-1615902
(State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)
     
1001 Air Brake Avenue, Wilmerding, Pennsylvania   15148
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code (412)-825-1000

 


 

Item 5. Other Items.

By press release dated March 22, 2004, Westinghouse Air Brake Technologies Corporation (the “Corporation”) announced that Gregory T. H. Davies, its President and Chief Executive Officer, will undergo treatment for cancer.

Item 7. Financial Statements; Proforma Financial Information and Exhibits.

(c) Exhibits.

     
Exhibit No.
  Description
Exhibit 99.1
  Press release dated March 22, 2004 regarding the matter referenced in Item 5.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

             
    WESTINGHOUSE AIR BRAKE
TECHNOLOGIES CORPORATION

(Registrant)
 
           
  By:   /s/ Alvaro Garcia-Tunon    
     
 
   
  Name:   Alvaro Garcia-Tunon    
Date: March 23, 2004
  Title:   Chief Financial Officer    

 


 

EXHIBIT INDEX

     
Exhibit    
Number
  Description and Method of Filing
Exhibit 99.1
  Press release dated March 22, 2004, filed here with.

 

Ex-99.1
 

Exhibit 99.1

         
( WABTEC LOGO)
       
  1001 Air Brake Avenue   PRESS RELEASE
  Wilmerding, PA 15148
Phone: 412.825.1543
   
  Fax: 412.825.1789    

Contact: Tim Wesley at (412) 825-1543

CEO Greg Davies To Undergo Cancer Treatment, With Full Recovery Expected; Management Team, Supported By Chairman Bill Kassling, To Assume His Duties

     WILMERDING, Pa., March 22, 2004 — Wabtec Corporation (NYSE: WAB) today announced that Gregory T.H. Davies, the company’s president and chief executive officer, will undergo treatment for cancer. Davies will have surgery this week to remove a brain tumor, followed by several weeks of radiation treatments. He is expected to make a full recovery and to return to the company after these treatments.

     In the meantime, Davies’ duties will be assumed by members of the Wabtec management team, with support from Chairman William E. Kassling.

     “In the past five years we have built a very capable and talented management team, and I’m confident the company will be in good hands,” Davies said. “Although the weeks ahead will be challenging for me, I’ll be receiving the best care and treatment available, since Pittsburgh is a renowned center of excellence in this field. I look forward to returning to my normal duties in June.”

     “Our top priority is to make sure that Greg can focus all his energy on recovery,” Kassling said. “Wabtec has a strong management team that will continue to execute the strategies and policies already in place until Greg returns.”

     Wabtec Corporation (www.wabtec.com) is one of North America’s largest providers of value-added, technology-based products and services for the rail industry.

####